Protocol Ledger

NCT07515079 · Phase III · RECRUITING

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

Interventional Phase III clinical trial protocol NCT07515079 sponsored by Bio-Thera Solutions in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-10-09 Enrollment: 406 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07515079
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)406 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07515079
Protocol FieldVerified Registry Value
NCT IdentifierNCT07515079
Consolidated Lead SponsorBio-Thera Solutions
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment406 participants (ESTIMATED)
Registered Start Date2024-10-09
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI